Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Last Updated: December 8, 2019

DrugPatentWatch Database Preview

Sebelipase alfa - Biologic Drug Details

See Plans and Pricing

« Back to Dashboard

Summary for sebelipase alfa

Tradenames:	1
Patents:	5
Applicants:	1
BLAs:	1
Suppliers: see list	1
Recent Clinical Trials:	See clinical trials for sebelipase alfa

Recent Clinical Trials for sebelipase alfa

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Alexion Pharmaceuticals	N/A
Alexion Pharmaceuticals	Phase 3
Alexion Pharmaceuticals	Phase 2

See all sebelipase alfa clinical trials

Pharmacology for sebelipase alfa

Ingredient-type	Lysosomal Acid Cholesterol Esterase

Patent Text Search: US Patents for sebelipase alfa

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Alexion Pharm	KANUMA	sebelipase alfa	INJECTABLE;INJECTION	125561	001	2015-12-08	Start Trial	Japan Atomic Energy Research Institute (Tokyo, JP)	1996-12-04	RX	Orphan	search
Alexion Pharm	KANUMA	sebelipase alfa	INJECTABLE;INJECTION	125561	001	2015-12-08	Start Trial		1998-05-26	RX	Orphan	search
Alexion Pharm	KANUMA	sebelipase alfa	INJECTABLE;INJECTION	125561	001	2015-12-08	Start Trial	Nippon Kayaku Kabushiki Kaisha (Tokyo, JP)	2007-04-17	RX	Orphan	search
Alexion Pharm	KANUMA	sebelipase alfa	INJECTABLE;INJECTION	125561	001	2015-12-08	Start Trial	Mitsubishi Gas Chemical Company, Inc. (Tokyo, JP)	2018-02-18	RX	Orphan	search
Alexion Pharm	KANUMA	sebelipase alfa	INJECTABLE;INJECTION	125561	001	2015-12-08	Start Trial	Corning Incorporated (Corning, NY)	2031-10-25	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for sebelipase alfa

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Germany	3788100	Start Trial
Japan	S6410943	Start Trial
Japan	S5294487	Start Trial
South Korea	19990072676	Start Trial
Taiwan	528792	Start Trial
European Patent Office	0261422	Start Trial
Japan	H0620539	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Express Scripts

Medtronic

Johnson and Johnson

Mallinckrodt

Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.